Following Flagship's origination of generative protein and mRNA platforms, Serif is pioneering Modified DNA medicines to program the foundational information layer of biology Serif to present data at ...
Flagship Pioneering launched Serif Biomedicines to create modified DNA drugs, taking the best features of mRNA and gene ...
With a few chemical tweaks and some dutiful protein partners, a new biotech from Flagship Pioneering thinks it has cracked ...
In a new study of women in post-menopause, white women with higher genetic risk of obesity regained weight about two times ...
Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...
The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger RNA to gene therapy.
Serif Biomedicines has emerged from stealth with $50 million in start-up funding. The new firm is developing what it calls ...
The DNA synthesis market offers significant growth opportunities driven by tailored therapies, DNA-based research, and diagnostics. Key market prospects include advancements in enzymatic synthesis, ...
Explore the contrasting acceptance of gene therapy and genetic crop modification, highlighting societal attitudes and ...
It’s #WorldMalaria Day Science is moving fast and for the first time, #EndMalaria is within reach. New vaccines, treatments, ...
1don MSN
Re-engineered human cells boost gene-editing particle potency across multiple delivery systems
Gene editing has emerged as a powerful approach for targeting the genetic causes of disease, but getting the editing ...
By Sriparna Roy April 23 (Reuters) - The U.S. Food and Drug Administration has approved Regeneron's gene therapy for a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results